Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

Case Comprehensive Cancer Center (Case CCC)

Status

Completed

Conditions

Cancer Pain

Oncology Pain

Treatments

Other: Reiki

Study type

Interventional

Funder types

Other

Identifiers

NCT06354049

CASE3Z24

Details and patient eligibility

About

The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.

Full description

Reiki is a biofield therapy originating in Japan, in which a trained practitioner places their hands on or above the body of a receiver or themselves to generate a relaxation and healing response. Systematic reviews and meta-analyses report Reiki to be effective for improving psychological and physical health symptoms. With respect to adults with cancer, Reiki has been shown to improve participants' relaxation, pain, fatigue, sleep, anxiety, stress, and wellbeing/quality of life compared to care as usual. However, one study showed no improvement in comfort and wellbeing in those receiving Reiki compared to sham Reiki control, but those receiving Reiki reported improvements above usual care.

Enrollment

10 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 18 - 89.
Neoplasm diagnosis (i.e., ICD-10 C00 - D49) confirmed in electronic health record (EHR)/Caisis
Receiving care at a UH Connor Whole Health Integrative Oncology Clinic.
Reporting at least three ESAS symptoms ≥4/10 at baseline screening including fatigue and ≥2 other symptoms on the 9-item questionnaire.
Able to speak and understand English.
Has an email address, and access to a computer with internet and/or a mobile device with a functioning data plan

Exclusion criteria

Significant cognitive impairment that has not been corrected.
Significant visual impairment that has not been corrected.
Unable to provide informed consent.
Active psychosis.
Pregnancy.
Metastatic disease.
Reiki therapy within 3 months of study enrollment
Active immunotherapy, chemotherapy, or radiation treatment, or completed within 3 months before study start. Aromatase inhibitors and tamoxifen are exceptions.